ClinicalTrials.gov record
Completed Phase 3 Interventional

A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors

ClinicalTrials.gov ID: NCT05306418

Public ClinicalTrials.gov record NCT05306418. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety, Efficacy and Exposure of Subcutaneously Administered NNC0365-3769 (Mim8) Prophylaxis in Children With Haemophilia A With or Without FVIII Inhibitors

Study identification

NCT ID
NCT05306418
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
70 participants

Conditions and interventions

Interventions

  • Mim8 Drug

Drug

Eligibility (public fields only)

Age range
1 Year to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 3, 2022
Primary completion
Nov 12, 2024
Completion
Nov 12, 2024
Last update posted
Nov 12, 2025

2022 – 2024

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Children's Hospital Los Angeles - Endocrinology Los Angeles California 90027
Univ of Colorado Sch of Med Aurora Colorado 80045
St Joseph's Hospital Foundation Tampa Florida 33607
Children's Healthcare Atlanta Atlanta Georgia 30322
Children's Hospital at Memorial Health Savannah Georgia 31404
University of Iowa_Iowa City Iowa City Iowa 52242
Univ Hosp Cleveland Med Ctr Cleveland Ohio 44106
Penn State MS Hershey Med Ctr Hershey Pennsylvania 17033-2360
St Christopher Hosp for Child Philadelphia Pennsylvania 19134

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05306418, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 12, 2025 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05306418 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →